Net gamma exposure for Jazz Pharmaceuticals Inc (JAZZ) options was positive at the Nov 4, 2026 close, about $4.12M per 1% move in the stock. It has been positive on 18 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for JAZZ, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for JAZZ, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for JAZZ, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
JAZZ Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is JAZZ gamma exposure positive or negative?
Jazz Pharmaceuticals net gamma exposure was positive on Nov 4, 2026, at $4.12M. It has been positive on 18 of the last 20 trading days.
How has JAZZ gamma exposure changed recently?
Jazz Pharmaceuticals net gamma exposure went from -$954.43K on Oct 7, 2026 to $4.12M on Nov 4, 2026. That is its highest reading in 12 weeks. See the JAZZ gamma exposure history for a longer view.
What is Jazz Pharmaceuticals Inc?
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology.